CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses-Reference-Cited by-同舟云学术

CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses

Published:2016-08-26 Issue:7 Volume:197 Page:2715-2725
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Hutten Tim J. A.^ORCID,Thordardottir Soley,Fredrix Hanny,Janssen Lisanne^ORCID,Woestenenk Rob,Tel Jurjen^ORCID,Joosten Ben^ORCID,Cambi Alessandra,Heemskerk Mirjam H. M.^ORCID,Franssen Gerben M.,Boerman Otto C.^ORCID,Bakker Lex B. H.^ORCID,Jansen Joop H.,Schaap Nicolaas^ORCID,Dolstra Harry,Hobo Willemijn^ORCID

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference58 articles.

1. Cancer immunotherapy via dendritic cells

2. Taking dendritic cells into medicine

3. Cross-presentation by dendritic cells

4. Cancer vaccines based on the identification of genes encoding cancer regression antigens

5. Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What influences the activity of Degrader−Antibody conjugates (DACs);European Journal of Medicinal Chemistry;2024-03

2. Mechanistic insights into the C-type lectin receptor CLEC12A-mediated immune recognition of monosodium urate crystal;Journal of Biological Chemistry;2024-03

3. Exploiting innate immunity for cancer immunotherapy;Molecular Cancer;2023-11-27

4. Lysosomal control of dendritic cell function;Journal of Leukocyte Biology;2023-09-29

5. Controlling Antigen Fate in Therapeutic Cancer Vaccines by Targeting Dendritic Cell Receptors;Molecular Pharmaceutics;2023-09-18